Literature DB >> 917121

[The regulation of acute inflammatory processes by systemic changes of plasma protein profiles].

R Scherer, G Ruhenstroth-Bauer.   

Abstract

Local inflammatory processes in the human as well as in experimental animals cause a selective increase or decrease of the hepatic synthesis rate of many plasma proteins. The resulting systemic changes in the plasma-protein profile regulate the extent of the local inflammatory response. The physiologic importance of this feedback mechanism is directed at preventing the spread of local inflammatory tissue destruction. By means of mediator substances involved in this regulatory system, the infalmmatory responses can be experimentally manipulated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 917121     DOI: 10.1007/bf00446258

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  35 in total

1.  Effect of leukocytic endogenous mediator on C-reactive protein in rabbits.

Authors:  C R Merriman; L A Pulliam; R F Kampschmidt
Journal:  Proc Soc Exp Biol Med       Date:  1975-07

2.  ELECTROPHORETIC MICROHETEROGENEITY OF SERUM ALPHA-1-ANTITRYPSIN.

Authors:  C B LAURELL
Journal:  Scand J Clin Lab Invest       Date:  1965       Impact factor: 1.713

3.  Plasma protein profiling: the diagnostic evaluation of disorders in plasma protein composition by a new immunoelectrophoretic method.

Authors:  R Scherer; G Ruhenstroth-Bauer
Journal:  Clin Chim Acta       Date:  1976-02-02       Impact factor: 3.786

4.  Non-steroidal anti-inflammatory drugs and leucocyte emigration.

Authors:  M Di Rosa; L Sorrentino; L Parente
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

5.  Quantitation of plasma 2 -AP globulin before and after stimulation with leukocytic extracts.

Authors:  C L Eddington; H F Upchurch; R F Kampschmidt
Journal:  Proc Soc Exp Biol Med       Date:  1972-02

6.  [Differentiated quantitative serum protein determination during myocardial infarct].

Authors:  G W Bachmann; M E Weiss; W Rapp
Journal:  Schweiz Med Wochenschr       Date:  1968-11-16

7.  Quantitative immunoelectrophoresis of human serum proteins.

Authors:  H G Clarke; T Freeman
Journal:  Clin Sci       Date:  1968-10       Impact factor: 6.124

8.  The anti-inflammatory actions of tilorone hydrochloride.

Authors:  H Megel; A Raychaudhuri; I Shemano; T H Beaver; L L Thomas
Journal:  Proc Soc Exp Biol Med       Date:  1975-05

9.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

10.  Studies on the pathogenesis of fever. XIV. Further observations on the chemistry of leukocytic pyrogen.

Authors:  G W Rafter; S F Cheuk; D W Krause; W B Wood
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

View more
  5 in total

1.  The effect of fibrinopeptides A and B on experimental allergic encephalomyelitis.

Authors:  R Scherer; J Simon; M Abd-el-Fattah; G Ruhenstroth-Bauer
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

2.  [Inhibition of the carrageenen-induced inflammatory rat paw oedema by systemic application of rat fibrinogen and fibrinopeptides (author's transl)].

Authors:  R Scherer; G Ruchenstroth-Bauer
Journal:  Blut       Date:  1978-06-20

3.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16

4.  Modulation of rat C-reactive protein serum level by dexamethasone and adrenaline--comparison with the response of alpha 2-acute phase globulin.

Authors:  R Schade; K Göhler; W Bürger; R Hirschelmann
Journal:  Agents Actions       Date:  1987-12

5.  The effect of D-galactosamine on plasma protein synthesis by the perfused rat liver from turpentine-stimulated donors.

Authors:  A Koj; A Dubin
Journal:  Br J Exp Pathol       Date:  1978-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.